[{"Assets_0_Q1_USD":44660000.0,"CommonStockSharesOutstanding_0_Q1_shares":28224447.0,"EarningsPerShareBasic_1_Q1_USD":-0.71,"EarningsPerShareDiluted_1_Q1_USD":-0.71,"NetIncomeLoss_1_Q1_USD":-19828000.0,"StockholdersEquity_0_Q1_USD":-4704000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":28045000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":28045000.0,"Ticker":"CTIC","CIK":"891293","name":"CTI BIOPHARMA CORP","OfficialName":"CTI BioPharma Corp. (DE) Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"472610380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170503"}]